动机性访谈对肺癌化学疗法初治患者焦虑抑郁情绪的影响

Effects of motivational interviewing on anxiety and depression in patients with lung cancer undergoing initial chemotherapy

目的探讨动机性访谈(motivational interviewing,MI)对肺癌化学疗法(化疗)初治患者焦虑抑郁情绪的影响。方法选择2015年5月—2016年4月收治的于术后转入科室接受治疗的肺癌化疗初治患者,并使用数字随机表法将纳入患者分为MI组和对照组。对照组给予常规护理,包括健康教育、心理护理、院外随访;MI组在常规护理基础上给予3次动机访谈和1次电话随访干预患者焦虑抑郁情绪。两组患者在入院时、化疗后1个月分别采用焦虑自评量表(Self-rating Anxiety Scale,SAS)、抑郁自评量表(Self-rating Depression Scale,SDS)和汉化版的心理痛苦温度计(Distress Thermometer,DT)进行评估。结果入院时,两组患者的SAS、SDS及DT得分差异无统计学意义(P>0.05)。化疗后1个月,MI组SAS、SDS及DT得分较入院时有所缓解,差异有统计学意义(P<0.05);MI组与同期对照组的SAS、SDS、DT评分比较,差异有统计学意义(P<0.05)。结论 MI可改善肺癌化疗初治患者的焦虑抑郁情绪,为临床医护人员干预肺癌化疗初治患者的不良心理情绪提供了依据。

Objective To explore the effect of motivational interviewing （MI） on anxiety and depression in patients with lung cancer undergoing initial chemotherapy. Methods From May 2015 to April 2016, patients with lung cancer who underwent initial chemotherapy after operation were collected and randomly divided into the control group and the MI group. The patients in the control group received traditional health education, psychological care, and post- discharge follow up; while the patients in the MI group were given routine nursing cares and three motivational interviews and one telephone follow up. At the admission and one month after chemotherapy, all patients were evaluated by the Self- rating Anxiety Scale （SAS）, Self-rating Depression Scale （SDS） and Distress Thermometer （DT）. Results At the admission, the SAS, SDS, and DT scores of patients in the two groups had no significant differences （P〉0.05）. After one month of chemotherapy, the SAS, SDS, and DT scores in the MI group were much better compared to the admission （P〈0.05）. The differences in the SAS, SDS, and DT scores between the two groups were significant （P〈0.05）. Conclusion MI can significantly alleviate anxiety and depression of patients with lung cancer undergoing initial chemotherapy.